Publications by authors named "R F Woolson"

Claim this Profile
F
Favipiravir in Patients With Early Mild-to-moderate Coronavirus Disease 2019 (COVID-19): A Randomized Controlled Trial.
Yoav Golan, Jesus Abraham Simon Campos, Rob Woolson, Donald Cilla, Rodolfo Hanabergh

Clin Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy.
Ankoor Shah, Jan Storek, Rob Woolson, Ashley Pinckney, Lynnette Keyes-Elstein

Rheumatology (Oxford)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Exposure-Response Perspective on the Clinical Dose of Pretomanid.
Jerry R Nedelman, David H Salinger, Vishak Subramoney, Rob Woolson, Karen Wade

Antimicrob Agents Chemother· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To condition or not condition? Analysing 'change' in longitudinal randomised controlled trials.
Cynthia J Coffman, David Edelman, Robert F Woolson

BMJ Open· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience.
Sharon D Yeatts, Renee H Martin, Christopher S Coffey, Patrick D Lyden, Lydia D Foster, Robert F Woolson

Stroke· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis